Cite
HARVARD Citation
Zimmerer, J. et al. (2022). Antibody‐suppressor CXCR5+CD8+ T cellular therapy ameliorates antibody‐mediated rejection following kidney transplant in CCR5 KO mice. American journal of transplantation. 22 (6), pp. 1550-1563. [Online].